Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CPRX - Catalyst Pharmaceuticals authorizes $40M share repurchase program; shares rise


CPRX - Catalyst Pharmaceuticals authorizes $40M share repurchase program; shares rise

Catalyst Pharmaceuticals (CPRX) has authorized the repurchase of up to $40M worth of its common shares.The company expects to use existing cash on hand for the repurchases.Catalyst is focuses on developing therapies for rare chronic neuromuscular and neurological diseases.Catalyst shares are up 8.5% to $4.74 in premarket trading.

For further details see:

Catalyst Pharmaceuticals authorizes $40M share repurchase program; shares rise
Stock Information

Company Name: Catalyst Pharmaceuticals Inc.
Stock Symbol: CPRX
Market: NASDAQ
Website: catalystpharma.com

Menu

CPRX CPRX Quote CPRX Short CPRX News CPRX Articles CPRX Message Board
Get CPRX Alerts

News, Short Squeeze, Breakout and More Instantly...